Shows / Derms on Drugs
Derms on Drugs
Derms on Drugs is where cutting-edge dermatology meets mediocre comedy. Each week three dermatologists – Matt Zirwas, Laura Ferris and Tim Patton – discuss, debate, and dissect the hottest topics in dermatology. It's everything you need to know to be on the cutting-edge of dermatology and it’ll be the most fun you’ve ever had while actually learning something useful. Derms on Drugs is produced by Scholars in Medicine, an online educational platform (scholarsinmedicine.com) exclusively for…
Episodes
- Derms on Drugs
The Hills Are Alive With New Targets
The Derms stay in Vienna for round two of EADV, where zombie-cell cream meets new pathways in HS and AD—plus a JAK surprise in PPP and reassuring pregnancy…
- Derms on Drugs
Better Croissants, Stranger Drugs
EADV serves up better croissants—and a packed menu of new mechanisms. The Derms dig into injectable RNA for BCC, a possible anti-scarring angle in HS, a TYK2…
Derms on DrugsThe Fast and the Urticarious
Dr. Jason Hawkes makes the case for putting speed first when choosing an advanced treatment for CSU. Remibrutinib works fast—but can he convince the Derms that…
- Derms on Drugs
High D, Low Certainty
The Derms size up high-dose vitamin D, a head-to-head lichen planus trial, and whether contact dermatitis testing is overcalling the culprit.
- Derms on Drugs
Custom Shots and Drug Cocktails
The Derms question treatment monogamy: a personalized melanoma vaccine joins forces with immunotherapy, while dual therapy takes on refractory HS and AD.
- Derms on Drugs
AI Crosses the Prescription Line
In Utah, AI is getting its hands on the prescription pad—starting with topical acne treatment. The Derms grill Nolla’s CEO on the big questions: Who catches…
Derms on DrugsThe Goldilocks Biologic
Dr. Steve Daveluy makes the case that Cosentyx is the “just right” first biologic for HS—but not every Derm is ready to move past TNFs. Durability, infection…
- Derms on Drugs
Tiny Vesicles, Big Claims
Exosomes may be real science, but the marketing has sprinted miles ahead of the data. The Derms dig into their promise for burns and epidermolysis bullosa—and…
- Derms on Drugs
Cuts, Switches, and Eight Extra Hairs
Three papers, three practical questions: Who really needs antibiotics before derm surgery? What comes after an AD drug fails? And does taking oral minoxidil in…
Derms on DrugsBlood, Sweat, and Hives
Dr. Marc Serota makes the case for targeted lab testing in CSU—but the Derms worry it may open a can of worms. The Chronic Urticaria Index gets a closer look…
- Derms on Drugs
Paging Dr. Telederm
After 70,000 virtual consults, Dr. Joe English knows what a photo can—and can’t—tell you. He joins the Derms to talk diagnostic curveballs, hospital saves, and…
- Derms on Drugs
Tregs, Tape, and Tresses
Three papers, three very different reactions: a Treg-boosting AD drug that may be too clever for its own good, a Steri-Strip trick you can use tomorrow, and…
Derms on DrugsDon’t Wait for the Tunnels
Convince the Derms on Drugs makes its debut with Dr. Christopher Sayed making the case for earlier systemic treatment in HS. Can he convince the Derms to act…
- Derms on Drugs
Patch Me If You Can
Patch first or treat first? The Hamann brothers join the Derms to tackle mystery dermatitis, questionable allergens, wet wraps, hand eczema—and why the answer…
- Derms on Drugs
The Clot Thickens
Three papers, three plot twists: new HS data that underwhelm on paper, a transected melanoma that may not need a sentinel node, and a possible explanation for…
- Derms on Drugs
The Long and Short of Male Genital Disease
Male genital disease expert Dr. Christopher Bunker joins the Derms for the penis episode no one else was brave enough to make. Lichen sclerosus, circumcision…
- Derms on Drugs
Three Sheets to Tofa
The Derms debut a shorter format with three papers and one newly dirt-cheap drug: generic tofacitinib. The safety, the risks, and the practicalities—right down…
- Derms on Drugs
Creams, Screams, and Measles
Pediatric dermatology legend Dr. Sheila Fallon Friedlander joins the Derms to sort through the new topical “Goldilocks” problem, take the sting out of Dupixent…
- Derms on Drugs
Can We Stop Referring CSU?
The CSU rulebook is getting a rewrite, and the Derms on Drugs crew has thoughts. Dr. Jason Hawkes joins the conversation to talk new guidelines, new therapies…
- Derms on Drugs
The Gray Zone Strikes Again
This week, the DoD tackle studies that leave plenty of room for debate—from skin cancer treatment costs and melanoma risk to HS, alopecia areata, and the…
- Derms on Drugs
Making Nails Sexy Again
The DOD tackle longitudinal melanonychia, retronychia, nail biopsies, and other everyday nail problems—with enough practical pearls to make you rethink your…
- Derms on Drugs
Clinical Controversies: Screening, Patch Testing & Physician Burnout
One paper questions melanoma screening. Another challenges patch testing. By the end, the conversation has wandered into studies on physician burnout and more…
- Derms on Drugs
What If the Biopsy Picked the Biologic?
Dermatologist William Damsky, MD, joins the DoD crew to explore immune biomarkers, treatment prediction, and whether precision dermatology is finally ready for…
- Derms on Drugs
Don't Blame the Canary
Burnout isn't just about long hours. From moral distress to prior authorizations and system barriers, this week's conversation with Dr. Lisa Swanson explores…
- Derms on Drugs
Bad Ideas, Good Outcomes, and Thin Melanomas
Thin melanomas that behave badly, a surprisingly intriguing role for oxybutynin in HS, and a reminder that some of dermatology’s most trusted assumptions…
- Derms on Drugs
When Psoriasis Pretends to Be Eczema (And Other Problems)
The diagnoses get messy, the treatment decisions get interesting, and the DoD crew has opinions. From a major scabies study to a practical overlap-disease…
- Derms on Drugs
French Bathhouses, Vitiligo Hacks & the Myth of the ‘Cure’
An emerging infection out of France, a surprisingly clever vitiligo combo, and a spirited debate about whether medicine has ever actually cured anything. Just…
- Derms on Drugs
Rewind: Melanoma Meltdowns, Biosimilar Betrayals, and the Eczema Enigma Exposed!
Melanoma, Anxiety, and Depression Links; Biosimilars vs Humira; Air Pollution and Atopic Dermatitis – Have We Finally Figured Out Why Eczema Is So Common and…
- Derms on Drugs
PsA: The Derm Version
Psoriatic arthritis usually gets explained in a way that makes derms want to leave the room. Not this episode. Drs. Zirwas, Ferris, and Patton are joined by…
- Derms on Drugs
Sunscreen Heresy & Other Hot Takes
This week’s Derms on Drugs is a classic six-pack episode. From cutting-edge CTCL therapies to biologic safety data and the growing world of oral…
- Derms on Drugs
Steroids, Estrogen & Other Bad Decisions
This week on Derms on Drugs, the gang goes deep into vulvar dermatology with double-boarded derm/OB-GYN expert Dr. Kelly Tyler. From lichen sclerosus and…
- Derms on Drugs
Pick Your Own Treatment Adventure
This week’s Derms on Drugs is a 6-pack that covers a little bit of everything and somehow lands on: just do what you want. From a randomized trial showing…
- Derms on Drugs
Regenerative Derm: Baloney or Breakthrough?
Feeling a little worn down by Friday? A bit… degenerated, perhaps? This week’s Derms on Drugs goes off the beaten path and into the world of regenerative…
- Derms on Drugs
When the Data Get Personal
This week’s Derms on Drugs 6-pack moves past theory and into real decisions—what actually helps you pick the rightdrug for the patient in front of you. From…
- Derms on Drugs
Derms on Drugs takes on the AAD late breaking research, Part 2
Couldn’t make it to Denver for AAD—or made it to Part 1 but still hungry for the rest? Derms on Drugs is back with Part 2, finishing the job with more of the…
- Derms on Drugs
Derms on Drugs takes on the AAD late breaking research, Part 1
Couldn't make it to Denver for the AAD conference? Made it to Denver but maybe had one too many Old Fashions to make it to the late breaking abstract…
- Derms on Drugs
What Actually Changes Practice (and What Doesn’t)
Some studies make you rethink everything. Others… not so much. This week, it’s a classic Derms on Drugs 6-pack that sorts through what’s actually useful…
- Derms on Drugs
The Episode You've Been Waiting For Your Whole Life
The Derms on Drugs get schooled on Hidradenitis Suppurativa by Dr. Chris Sayed from the University of North Carolina. This will be one of the most practically…
- Derms on Drugs
Melanoma, EMPD, and a Prostate Drug Walk Into a Bar...
Melanoma, extramammary paget's and a prostate cancer drug walk into a bar... well, it may sound like a joke, but this week's episode is no laughing matter!…
- Derms on Drugs
Tissue Issues: A Deep Dive into Cutaneous Connective Tissue Disease
Matt, Laura, and Tim are joined by Dr. Lauren Graham (UAB) for a deep dive into cutaneous connective tissue disease. They cover the latest in lupus treatment —…
- Derms on Drugs
Lasers, Scabies & Dupixent Dilemmas
The Derms on Drugs are back it, answering the burning questions you didn't know you had. This week's hot topics: Aviclear laser new data just dropped…
- Derms on Drugs
The Derms on Drugs Bust Myths and Make Life Easier for Derms This Week
Big news on TB Tests for psoriasis patients on biologics! New official recommendations say not necessary for IL-17s and IL-23s. Literally zero cases. Ever…
- Derms on Drugs
Melasma, and Vitiligo, and Warts, Oh My!
The Derms on Drugs are back at it, answering the burning derm questions you didn't even know you had. Join us this week as we dive into more "outside the box"…
- Derms on Drugs
Outside the Box for Atopic Dermatitis
The Derms on Drugs are joined by Dr. Peter Lio to take a dive into the "root causes" of atopic dermatitis and what we can do to address them. Maybe you've…
- Derms on Drugs
Why you shouldn't ever use Bactrim for acne (and other new info you don't want to miss)
This week's episode will help you not get sued, talk to psoriasis patients about diet, manage transplant patients with skin cancer and more. Join us again this…
- Derms on Drugs
Will AI Take Your Job?
The Derms on Drugs bring in a heavy hitter straight out of silicon valley to talk AI and the future of dermatology. Dr. Faranak Kamangar is a Board Certified…
- Derms on Drugs
More Answers for Tough Questions
The Derms on Drugs give the definitive answer to the age old question: What came first, the chicken or the egg? You'll have to listen to find out. What's a…
- Derms on Drugs
Drugs, Drugs and More Drugs
Get ready for a no-nonsense tour-de-force of practical application in the latest derm literature. Pipeline drugs, new approvals, brand names, generics—and HS…
- Derms on Drugs
What Do Kidney Failure, Short Kids and the Vagus Nerve Have in Common?
Listening this week could save your life (well, at least your kidneys). Find out what common ingredient in keratin treatments you (and your friends, family and…
- Derms on Drugs
What If Every Day Was a Bad Hair Day?
Admit it—bad hair days are the worst. Now imagine every day is one. Alopecia’s psychological impact is way deeper (and more surprising) than most people think…
- Derms on Drugs
Boosting Isotretinoin, Outsmarting Botox Resistance & Other Plot Twists
This week, the Derms on Drugs are back with another literature speed-run—think 3D chess meets derm nerd nirvana. We’re answering questions you didn’t even know…
- Derms on Drugs
The Best Central Centrifugal Scarring Alopecia Discussion You've Ever Heard
The Derms on Drugs are joined by Dr. Crystal Aguh from Johns Hopkins for an AMAZING discussion on central centrifugal scarring alopecia. From uber practical…
- Derms on Drugs
From Blood Vessels to Mighty Mites: What’s Hot (and maybe not) in Dermatology Right Now
Join us this week as the Derms on Drugs crew discusses the latest in the Dermatology literature. Topics for this episode include: - Cutaneous vasculitis of the…
- Derms on Drugs
Pediatric Psoriasis
You don't see a lot of kids with psoriasis, but when you do it can be a big challenge, especially if it's bad and they need a systemic. The Derms on Drugs are…
- Derms on Drugs
Are You Serious? Tattoos Prevent Melanoma and More Curiosities from the Literature
Brought to you by Scholars In Medicine The Derms on Drugs take on the latest, greatest and coolest stuff from the Derm literature. Quite honestly, there was…
- Derms on Drugs
Obesity, GLP-1s and Dermatology
Join the Derms on Drugs and Dr. Shanthi Narla as we dive into the world of obesity, GLP-1s and dermatology. Whatever you think about all of these topics, we…
- Derms on Drugs
Dermatology Update: The New, The Old, The Common and The Rare
Join the Derms on Drugs as we slice and dice the latest dermatology literature. We've got stuff that will change what you do next week, answers for uncommon…
- Derms on Drugs
Dermatology Update: The New, The Old, The Common and The Rare
Join the Derms on Drugs as we slice and dice the latest dermatology literature. We've got stuff that will change what you do next week, answers for uncommon…
- Derms on Drugs
Network Meta-Analyses in Dermatology: Can You Trust the Data? Expert Insights with Dr. Aaron Drucker
Ever wonder if you can trust those network meta-analyses (NMAs) flooding dermatology journals? Join the Derms on Drugs and University of Toronto expert Dr…
- Derms on Drugs
Rashes, Pre-cancers, and Cancers – we've got the answers!
Welcome back to Derms on Drugs! Today we’re cracking open a six-pack—not IPAs, but papers. We’ve got polyomavirus antibodies sneaking in as early markers for…